Hess Corporation (NYSE:HES) today reported adjusted net income, which
excludes items affecting comparability, of $53 million or $0.18 per
common share, for the fourth quarter of 2014 compared with $319 million
or $0.96 per share in the fourth quarter of 2013.
NRG Renew, a wholly owned subsidiary of NRG Energy, Inc. (NYSE:NRG), and
SunShare, one of the country’s first and fastest-growing community solar
companies, are partnering to finance and build 8.2 megawatts (MWac) of
community solar projects along the Front Range of Colorado (including
Colorado Springs and Denver), which is enough to power more than 1,600
homes for 20 years.
Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards
Bank & Trust Company, with offices in the Louisville, Indianapolis and
Cincinnati metropolitan markets, today reported results for the fourth
quarter and year ended December 31, 2014, with earnings per diluted
share of $0.59 and $2.36, respectively.
SKF (STO:SKFA)(STO:SKFB)(Pink Sheets:SKFRY)(LSE:SKFB)
Alrik Danielson, President and CEO:
”Demand was in line with our expectations for the quarter with growth,
in volume terms, just under 2%. Our industrial business gained some
momentum while, as expected, the automotive business slowed somewhat.
Great Western Bancorp, Inc. (NYSE: GWB) today reported net income of
$26.7 million, or $0.46 per share, for the quarter ended December 31,
2014, compared to net income of $28.6 million, or $0.49 per share, for
the same quarter of fiscal year 2014.
Tessera Technologies, Inc. (NASDAQ: TSRA) ("Tessera" or the “Company")
will announce its financial results for the fourth quarter and fiscal
year ended December 31, 2014 on February 10, 2015, following the close
of the market.
The ADT Corporation (NYSE:ADT):
FIRST QUARTER 2015 FINANCIAL HIGHLIGHTS
GAAP: revenue of $887 million, net income of $72 million, diluted EPS
of $0.41, operating cash flow of $369 million
Diluted EPS before special items of $0.51 (1) , up 18.6% from
Recurring revenue of $825 million, up 6.5% or 7.1% in constant currency (1)(2)
EBITDA before special items of $453 million (1) , up $27
million or 6.3%
EBITDA margin before special items of 51.1% (1) , up 30 basis
points from prior year
Operating cash flow before special items $390 million (1) ,
up $48 million or 14.0% from prior year
Steady-state free cash flow of $893 million (1) , up $106
million or 13.5% from prior year
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical
company focused on the discovery, development and commercialization of
novel protein therapeutics for cancer and rare diseases, today announced
it will participate in the following upcoming investor conferences.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.